This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medimmune Limited. Active years: 2018.
Company Filing History:
2 out of 546 
Years Active: 2018
Title: Anthony Celeste: Innovator in Anti-PCSK9-GLP-1 Fusions
Introduction
Anthony Celeste is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions. His work focuses on anti-PCSK9-GLP-1 fusions, which have the potential to impact the treatment of various health conditions.
Latest Patents
Anthony Celeste holds 1 patent for his invention titled "Anti-PCSK9-GLP-1 fusions and methods for use." This patent outlines the methods and applications of these fusions, showcasing his commitment to advancing medical science.
Career Highlights
Currently, Anthony is employed at MedImmune Limited, a leading biotechnology company. His role at MedImmune allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Throughout his career, Anthony has worked alongside talented colleagues, including Cristina Rondinone and Joseph Grimsby. These collaborations have fostered an environment of innovation and creativity, further enhancing the impact of their collective work.
Conclusion
Anthony Celeste is a distinguished inventor whose work in anti-PCSK9-GLP-1 fusions exemplifies the spirit of innovation in biotechnology. His contributions are paving the way for new therapeutic approaches that could benefit many patients in the future.